Dr. Zuckerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
190 E Bannock St
Boise, ID 83712Phone+1 208-381-2790Fax+1 208-381-4025
Summary
- Dr. Dan Zuckerman is the executive medical director of St. Luke's Mountain States Tumor Institute (MSTI) in Boise, ID. He received his medical degree from University of Chicago Pritzker School of Medicine and trained at Brigham and Women's Hospital and Dana-Farber Cancer Institute and has been in practice 15 years. He specializes in gastrointestinal cancer.
Clinical Expertise
- Gastrointestinal oncology, Hematologic oncology
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2005 - 2008
- Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2005
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2002
Certifications & Licensure
- FL State Medical License 2024 - 2027
- AR State Medical License 2023 - 2026
- ND State Medical License 2023 - 2026
- CA State Medical License 2024 - 2026
- MI State Medical License 2023 - 2026
- WA State Medical License 2023 - 2026
- VA State Medical License 2023 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Phi Beta Kappa Williams College
- Alpha Omega Alpha University of Chicago Pritzker School of Medicine
Clinical Trials
- Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer Start of enrollment: 2007 Jun 01
- Study of Vitamin D in Untreated Metastatic Colorectal Cancer Start of enrollment: 2012 Apr 13
- T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- 56 citationsSurveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis.Alfred Ian Lee, Dan S. Zuckerman, Annick D. Van den Abbeele, Suzanne L. Aquino, Diane Crowley
Cancer. 2010-08-15 - 142 citationsVeteran's affairs hospital discharge databases coded serious bacterial infections accurately.Sebastian Schneeweiss, Ari Robicsek, Richard E. Scranton, Dan Zuckerman, Daniel H. Solomon
Journal of Clinical Epidemiology. 2007-04-01 - 40 citationsRare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfallsEvan A. Farkash, Judith A. Ferry, Nancy L. Harris, Ephraim P. Hochberg, Ronald W. Takvorian
Journal of Hematopathology. 2009-08-20
Press Mentions
- Perry Brown and Dan Zuckerman: Laws Criminalizing Medical Care Are Weakening Health Care for IdahoansMarch 11th, 2023
- Delays in CT Imaging for Cancer Still Persist After COVID-19 Pandemic, Study FindsNovember 24th, 2021
- With Hospitals Crowded from COVID, 1 in 5 American Families Delays Health CareOctober 14th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: